Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial - Concepedia

Concepedia

Publication | Closed Access

Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial

96

Citations

48

References

2013

Year

Kunitoshi Iseki, H. Arima, Kentaro Kohagura, Ichiro Komiya, Shinichiro Ueda, Kunpei Tokuyama, Yoshiki Shiohira, H Uehara, Shigeki Toma, Naoki Tomiyama,

Nephrology Dialysis Transplantation

Abstract

BP-lowering treatment with an ARB did not significantly lower the risks of major cardiovascular events or death among patients with hypertension on chronic HD. (Cochrane Renal Group Prospective Trial Register number CRG010600030).

References

	Year	Citations

Page 1